Company intelligence / Profile preview

NexPharm

Berlin, Germany

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

NextPharma is a leading European CDMO serving over 70 markets worldwide, with expertise in solids, liquids, semi-solids, hormones, penicillins, cephalosporins, and ophthalmics. Known for stringent quality (FDA, EMA, Anvisa regulated), sustainability initiatives (carbon neutrality focus), and robust manufacturing scale (>8 billion tablets/year).

Modalities: Small moleculeBiologicHormoneBeta lactam antibioticControlled substanceOphthalmic productNutraceutical
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on NexPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NexPharm.

Explore the full profile